Treatment Effect of Percutaneous Coronary Intervention in Men Versus Women With ST-Segment-Elevation Myocardial

Samian Sulaiman1, Akram Kawsara1, Mohamed O Mohamed2

  • 1Division of Cardiology West Virginia University Morgantown WV.

Insights

Primary percutaneous coronary intervention (pPCI) offers similar mortality benefits for both men and women with ST-segment-elevation myocardial infarction. Despite comparable outcomes, women receive pPCI less often than men in current US practice.

Area of Science:

  • Cardiology
  • Public Health
  • Health Services Research

Background:

  • Women experience worse outcomes with primary percutaneous coronary intervention (pPCI) compared to men, potentially due to risk aversion.
  • The comparative mortality benefit of pPCI between sexes remains under-explored.

Purpose of the Study:

  • To investigate whether pPCI provides a comparable mortality benefit for men and women with ST-segment-elevation myocardial infarction (STEMI).
  • To analyze sex-based differences in pPCI utilization, outcomes, and associated costs.

Main Methods:

  • Analysis of the National Inpatient Sample (2016-2018) for STEMI admissions.
  • Utilized propensity-score matching to assess the average treatment effects of pPCI on mortality, complications, length of stay, and cost.
  • Conducted sensitivity analyses using logit models and marginal effect calculations.

Main Results:

  • A total of 413,500 hospitalizations were analyzed, with women comprising 30.7%. Women presented with more comorbidities but were less likely to undergo pPCI (74.0% vs. 82.0%).
  • pPCI demonstrated comparable average treatment effects on in-hospital mortality for both women (-9.5%) and men (-8.4%) (P interaction=0.16).
  • Treatment effects on major complications were similar, except for acute stroke. The proportional cost increase associated with pPCI was higher in women.

Conclusions:

  • pPCI significantly reduces in-hospital mortality in STEMI patients, with comparable benefits observed in both men and women.
  • Despite similar mortality benefits, women continue to have lower rates of pPCI utilization in contemporary US healthcare settings.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
134
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
53
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
71
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
56
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
84
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
66